每年研究成果
每年研究成果
研究成果
搜尋結果
-
2020
Correction to: Chemotherapy Immunophenoprofiles in Non-Small-Cell Lung Cancer by Personalized Membrane Proteomics (PROTEOMICS - Clinical Applications, (2018), 12, 2, (1700040), 10.1002/prca.201700040)
Utami Putri, D., Feng, P. H., Hsu, Y. H., Lee, K. Y., Jiang, F. W., Kuo, L. W., Chen, Y. J. & Han, C. L., 三月 1 2020, 於: Proteomics - Clinical Applications. 14, 2, 1970064.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
2019
Corrigendum to “Classification of lung cancer subtypes based on autofluorescence bronchoscopic pattern recognition: A preliminary study” [Comput Methods Programs Biomed. 163 (2018) 33–38](S0169260717314918)(10.1016/j.cmpb.2018.05.016)
Feng, P. H., Chen, T. T., Lin, Y. T., Chiang, S. Y. & Lo, C. M., 十二月 2019, 於: Computer Methods and Programs in Biomedicine. 182, 105095.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
2018
Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146
Feng, P. H., Yu, C. T., Chen, K. Y., Luo, C. S., Wu, S. M., Liu, C. Y., Kuo, L. W., Chan, Y. F., Chen, T. T., Chang, C. C., Lee, C. N., Chuang, H. C., Lin, C. F., Han, C. L., Lee, W. H. & Lee, K. Y., 七月 31 2018, 於: Oncotarget. 9, 59, p. 31559 1 p.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
-
2017
Corrigendum: SUV39H1 Reduction Is Implicated in Abnormal Inflammation in COPD
Chen, T. T., Wu, S. M., Ho, S. C., Chuang, H. C., Liu, C. Y., Chan, Y. F., Kuo, L. W., Feng, P. H., Liu, W. T., Chen, K. Y., Hsiao, T. C., Juang, J. N. & Lee, K. Y., 十二月 22 2017, 於: Scientific Reports. 7, 1 p., 46924.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取